Chlamydia pneumoniae-IN-1

Research use only, not for human use.

Chlamydia pneumoniae-IN-1 (compound 55), a benzimidazole derivative, exhibits potent antibacterial activity, inhibiting 99% of C. pneumoniae growth at a concentration of 10 μM while maintaining 95% viability of host cells.

Chlamydia pneumoniae-IN-1 (compound 55), a benzimidazole, shows high activity against the bacterium. Chlamydia pneumoniae-IN-1 has 99% inhibition of C. pneumoniae Growth at 10 μM, and has 95% inhibition effect on the viability of the host cells at 10 μM. Chlamydia pneumoniae-IN-1 inhibits the growth of the CV-6 strain with a MIC of 12.6 μM. Chlamydia pneumoniae-IN-1 has antichlamydial efficiency.

——

——

——

GPCR/G Protein

Antibacterial

Antibacterial

——

——

518010-44-1

333.41

C19H15N3OS

>98% (HPLC)

——

O=C(NC1=CC=CC(=C1)C2=NC3=CC=C(C=C3N2)C)C=4SC=CC4

——

(-20℃)

With Ice Pack

≥ 2 years